Source: American Academy of Family Physicians’ Advocacy Insider
On July 16, the American Academy of Family Physicians provided input to Health and Human Services on the “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.”
The AAFP letter and related In the Trenches blog post emphasized that managing prescription drug prices for patients is an important concern for family physicians. Family physicians can have a real impact on the drug pricing debate, in part because they understand the complexity of care they provide and the fact that the sheer number of conditions, complaints and diseases seen in family medicine is far greater than those seen by any other physician specialty.
The AAFP letter focused on a set of policy recommendations that involve generic drug access, site-neutral payments, value-based drug pricing, Medicare negotiation authority, transparency, and Medicare Part B drugs. The AAFP will continue to work with the administration, Congress, and coalition partners to advance policies that make prescription drugs more accessible and affordable for patients.